ViAqua Therapeutics Announces $4.3 Million Investment led by S2G Ventures for its RNA-based Aquaculture Health Platform
June 9, 2021
Financing will support the commercialization of the first product aimed at improving health in shrimp and support the development of additional products to improve aquatic animal health and nutrition.
News of this announcement also appeared in —
Thai Union Corporate Venture Fund Expands Into Biotechnology; Invests in RNA-based Aquaculture Health Platform
June 10, 2021
Thai Union Group PCL has invested in biotechnology company ViAqua Therapeutics through its venture fund, joining other industry-leading strategic and financial partners in backing the start-up. At left: Thai Union Group PCL CEO Thiraphong Chansiri
News of this announcement also appeared on —
Opportunities & Challenges at Fish 2.0
December 10, 2017
As a finalist in the recent Fish 2.0 International Business Competition, held at Stanford University in California, I had a great opportunity to present in front of highly experienced, well-regarded aquaculture experts during the various stages of the competition.